Informatie:
Fout:
ID
33349
Beschrijving
Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00788333
Link
https://clinicaltrials.gov/show/NCT00788333
Trefwoorden
Versies (1)
- 06-12-18 06-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
6 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00788333
Eligibility Breast Cancer NCT00788333
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00788333
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
HER2-positive carcinoma of breast Advanced Locally | HER2-positive carcinoma of breast metastatic | Tuzumab Regimen Quantity failed | Pharmaceutical Preparations HER2 Targeted | lapatinib | pertuzumab | Trastuzumab-DM1
Item
subjects with locally advanced or metastatic her-2-positive breast cancer who have failed at least one trastuzumab containing regimen. prior treatment with other her-2-targeted agents (e.g. lapatinib, pertuzumab, trastuzumab dm-1 etc.) is allowed
boolean
C1960398 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1960398 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3,1])
C0040808 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0231175 (UMLS CUI [3,4])
C0013227 (UMLS CUI [4,1])
C0069515 (UMLS CUI [4,2])
C1521840 (UMLS CUI [4,3])
C1506770 (UMLS CUI [5])
C1328025 (UMLS CUI [6])
C2935436 (UMLS CUI [7])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1960398 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3,1])
C0040808 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0231175 (UMLS CUI [3,4])
C0013227 (UMLS CUI [4,1])
C0069515 (UMLS CUI [4,2])
C1521840 (UMLS CUI [4,3])
C1506770 (UMLS CUI [5])
C1328025 (UMLS CUI [6])
C2935436 (UMLS CUI [7])
HER2-positive carcinoma of breast
Item
histologic or cytologic diagnosis of her-2-positive breast cancer
boolean
C1960398 (UMLS CUI [1])
ECOG performance status
Item
ecog status 0 - 1
boolean
C1520224 (UMLS CUI [1])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
Condition Requirement Steroids chronic
Item
any condition requiring chronic use of steroids
boolean
C0348080 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,3])
C0205191 (UMLS CUI [1,4])
C1514873 (UMLS CUI [1,2])
C0038317 (UMLS CUI [1,3])
C0205191 (UMLS CUI [1,4])
Abnormal glucose homeostasis | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Symptoms Prediabetic
Item
any disorder with dysregulation of glucose homeostasis (history of type 1 or 2 diabetes mellitus or prediabetic symptoms
boolean
C4023598 (UMLS CUI [1])
C0011854 (UMLS CUI [2])
C0011860 (UMLS CUI [3])
C1457887 (UMLS CUI [4,1])
C0362046 (UMLS CUI [4,2])
C0011854 (UMLS CUI [2])
C0011860 (UMLS CUI [3])
C1457887 (UMLS CUI [4,1])
C0362046 (UMLS CUI [4,2])
Glucose intolerance
Item
history of glucose intolerance
boolean
C0271650 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Unwilling | Childbearing Potential Contraceptive methods Unable
Item
women of child-bearing potential unwilling or unable to use acceptable contraception methods
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])